Drugs · Entity Annotation Prototype (beta)

1articles mentioning drugs

1drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: interleukin 6 inhibitors ×

interleukin 6 inhibitors

This drug is selected. Its supporting articles are shown below.

interleukin 6 inhibitors1

Articles mentioning interleukin 6 inhibitors

1 articles · page 1 of 1

Impact of trial exclusion criteria on real-world comparative effectiveness of targeted therapies in rheumatoid arthritis: the FIRST Registry

rmdopen · abstract · 2026-05-18 · 1 matching annotations

91.3%

interleukin 6 inhibitors b/tsDMARDs tumour necrosis factor inhibitors CTLA4-Ig Janus kinase (JAK) inhibitors rheumatoid arthritis b/tsDMARDs

… The proportion ineligible differed by b/tsDMARDs, highest with interleukin 6 inhibitors (47.4%) and CTLA4-Ig (45.1%) and lowest with Janus kinase (JAK)…

Browse drugs

interleukin 6 inhibitors

Articles mentioning interleukin 6 inhibitors

Impact of trial exclusion criteria on real-world comparative effectiveness of targeted therapies in rheumatoid arthritis: the FIRST Registry